Qube Research & Technologies Ltd
Position in IMDX — Insight Molecular Diagnostics Inc.
CIK 1729829
LONDON, X0
Position in IMDX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$82,754
-$129,878 QoQ
Shares Held
25,230
-11.0% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMDX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $925,783,255 across 15 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
492,580 | $246,959,908 | |
| 2 | A |
Agilent Technologies, Inc.
|
1,415,364 | $188,002,800 | |
| 3 | DHR |
Danaher Corp /De/
|
844,514 | $160,863,026 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
148,395 | $78,121,063 | |
| 5 | DGX |
Quest Diagnostics Inc
|
343,398 | $72,783,206 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
279,086 | $53,924,996 | |
| 7 | NTRA |
Natera, Inc.
|
161,079 | $43,724,894 | |
| 8 | GH |
Guardant Health, Inc.
|
156,236 | $23,440,087 |
All Filings in IMDX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $82,754 | 25,230 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $212,632 | 28,351 | Shares | Sole | 2026-02-17 | |
| 2024-06-30 | $2 | 1 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2 | 1 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2 | 1 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3 | 1 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||